Table 5.
Natural Killer (NK)-cell subsets pre-exercise, post-exercise, and 30-min post-exercise in participants with smouldering multiple myeloma with percentage change (%Δ) pre-to post-exercise and main effect of time from repeated measures ANOVA. Data are mean ± SD, n = 8.
| CD3−CD56+ cells/μL | Pre-exercise | Post-exercise | 30-min post-exercise | %Δ pre- to post-exercise | Effect of time |
|---|---|---|---|---|---|
| Total | 53 ± 21 | 203 ± 119a | 36 ± 14a,c | 302 ± 183 | F(1.02,7.16) = 14.66, p = 0.006, ηp2 = 0.68 |
| CD16+ | 46 ± 20 | 190 ± 117a | 30 ± 12a,c | 348 ± 220 | F(1.02,7.15) = 14.04, p = 0.007, ηp2 = 0.67 |
| CD38+ | 50 ± 19 | 191 ± 116a | 34 ± 14a,c | 305 ± 199 | F(1.02,7.15) = 13.82, p = 0.007, ηp2 = 0.66 |
| CD38+CD16+ | 43 ± 19 | 177 ± 113a | 27 ± 11a,c | 352 ± 239 | F(1.02,7.16) = 13.19, p = 0.008, ηp2 = 0.65 |
| CD38+CD16− | 7 ± 2 | 16 ± 8b | 6 ± 3d | 145 ± 94 | F(1.06,7.44) = 21.81, p = 0.002, ηp2 = 0.76 |
| CD38−CD16+ | 2 ± 2 | 6 ± 7 | 2 ± 1 | 135 ± 113 | F(1.01,7.03) = 3.85, p = 0.090, ηp2 = 0.36 |
| CD57+ | 31 ± 14 | 133 ± 92a | 20 ± 11a,c | 339 ± 209 | F(1.01,7.09) = 11.83, p = 0.010, ηp2 = 0.63 |
| CD57− | 22 ± 8 | 70 ± 32a | 16 ± 4d | 247 ± 145 | F(1.06,7.43) = 19.92, p = 0.002, ηp2 = 0.74 |
| CD57+CD16+ | 30 ± 14 | 126 ± 92a | 19 ± 10a,c | 349 ± 236 | F(1.01,7.08) = 10.68, p = 0.013, ηp2 = 0.60 |
| CD57−CD16+ | 17 ± 8 | 59 ± 32a | 11 ± 3a,c | 299 ± 200 | F(1.05,7.32) = 16.01, p = 0.005, ηp2 = 0.70 |
| CD56dim | 50 ± 20 | 194 ± 116a | 33 ± 13a,c | 313 ± 190 | F(1.02,7.15) = 14.60, p = 0.006, ηp2 = 0.68 |
| CD56dimCD38+CD16+ | 42 ± 18 | 174 ± 110a | 27 ± 11a,c | 359 ± 245 | F(1.02,7.14) = 13.36, p = 0.008, ηp2 = 0.66 |
| CD56dimCD38+CD16− | 5 ± 2 | 13 ± 7a | 4 ± 3c | 170 ± 126 | F(1.05,7.33) = 15.85, p = 0.005, ηp2 = 0.69 |
| CD56dimCD38−CD16+ | 3 ± 2 | 6 ± 7 | 2 ± 1 | 124 ± 122 | F(1.05,7.35) = 3.23, p = 0.113, ηp2 = 0.32 |
| CD56bright | 3 ± 2 | 8 ± 4a | 3 ± 1c | 145 ± 80 | F(1.09,7.65) = 12.97, p = 0.007, ηp2 = 0.65 |
| CD56brightCD38+CD16+ | 1 ± 1 | 3 ± 3 | 1 ± 1 | 224 ± 182 | F(1.11,7.79) = 5.85, p = 0.040, ηp2 = 0.46 |
| CD56brightCD38+CD16− | 2 ± 1 | 3 ± 2a | 2 ± 1d | 115 ± 71 | F(1.13,7.92) = 17.14, p = 0.003, ηp2 = 0.71 |
| CD56brightCD38−CD16+ | 0.1 ± 0.1 | 0.2 ± 0.3 | 0.1 ± 0.1 | 182 ± 232 | F(2,14) = 2.38, p = 0.15, ηp2 = 0.25 |
ANOVA, analysis of variance.
a
indicates a significant difference from pre-exercise at p < 0.05.
b
indicates a significant difference from pre-exercise at p < 0.01.
c
indicates a significant difference from post-exercise at p < 0.05.
d
indicates a significant difference from post-exercise at p < 0.01.